NDA 203887 describes DAPSONE, which is a drug marketed by
Alembic,
Amneal,
Beloteca,
Cosette,
Encube,
Mylan,
Padagis Israel,
Taro,
Torrent,
Zydus,
Actavis Llc,
Alvogen,
Chartwell Rx,
Everest Life Sci,
Nostrum Labs Inc,
Novitium Pharma, and
Rising, and is included in twenty-two NDAs. It is available from
twenty-three suppliers. Additional details are available on the
DAPSONE profile page.
The generic ingredient in DAPSONE is
dapsone. There are eight
drug master file entries for this compound. Twenty-six
suppliers are listed for this compound. Additional details are available on the
dapsone profile page.